CVE-2025-15066: CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') in Innorix Innorix WP
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Missing Authorization vulnerability in Innorix WP allows Path Traversal.This issue affects Innorix WP from All versions If the "exam" directory exists under the directory where the product is installed (ex: innorix/exam)
AI Analysis
Technical Summary
CVE-2025-15066 is a path traversal vulnerability classified under CWE-22 and CWE-862 affecting Innorix WP, a product by Innorix. The vulnerability arises from improper limitation of pathnames to restricted directories, allowing an attacker to traverse directories beyond the intended scope. Specifically, if an 'exam' directory exists under the installation directory (e.g., innorix/exam), the product fails to properly restrict pathname inputs, enabling unauthorized access to files outside the intended directory. The vulnerability does not require authentication or user interaction but does require local access (AV:L), meaning an attacker must have some level of access to the system to exploit it. The CVSS 4.0 base score is 6.9 (medium severity), reflecting a moderate impact primarily on confidentiality due to unauthorized file access. The vulnerability does not affect integrity or availability directly and does not involve network attack vectors. No patches or known exploits are currently available, indicating the need for proactive mitigation. The issue was published on December 29, 2025, and remains a concern for all versions of Innorix WP where the 'exam' directory exists. The vulnerability is significant because it can lead to unauthorized disclosure of sensitive information, potentially exposing confidential data or configuration files critical to system security.
Potential Impact
For European organizations, this vulnerability poses a risk of unauthorized disclosure of sensitive information stored within or accessible via the Innorix WP installation directories. Organizations in sectors such as education, healthcare, or government that may use Innorix WP with the 'exam' directory are particularly vulnerable. The impact is primarily on confidentiality, as attackers can read files outside the intended directory scope. This could lead to exposure of personal data, intellectual property, or system configuration files, potentially facilitating further attacks. Since exploitation requires local access, the threat is higher in environments where multiple users have system access or where attackers can gain initial footholds through other means. The lack of authentication requirement means that once local access is obtained, attackers can exploit the vulnerability without further barriers. The absence of known exploits in the wild reduces immediate risk but does not eliminate the potential for future exploitation. European organizations must consider this vulnerability in their risk assessments, especially those with Innorix WP deployments in critical infrastructure or regulated industries subject to strict data protection regulations like GDPR.
Mitigation Recommendations
1. Immediately verify if the 'exam' directory exists under the Innorix WP installation path; if it is not required, remove or rename it to prevent exploitation. 2. Implement strict input validation and sanitization on all pathname inputs within Innorix WP to ensure traversal sequences (e.g., '../') are blocked or properly handled. 3. Restrict local access to systems running Innorix WP to trusted users only, employing strong access controls and monitoring. 4. Monitor file system access logs for unusual or unauthorized attempts to access directories outside the intended scope, especially targeting the 'exam' directory or parent directories. 5. If possible, isolate Innorix WP installations in segmented network zones to limit lateral movement in case of compromise. 6. Engage with Innorix vendor support to obtain patches or official guidance once available. 7. Conduct regular security audits and penetration testing focusing on path traversal and authorization bypass vulnerabilities. 8. Educate system administrators and users about the risks of local privilege escalation and path traversal attacks to enhance detection and response capabilities.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, Sweden
CVE-2025-15066: CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') in Innorix Innorix WP
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Missing Authorization vulnerability in Innorix WP allows Path Traversal.This issue affects Innorix WP from All versions If the "exam" directory exists under the directory where the product is installed (ex: innorix/exam)
AI-Powered Analysis
Technical Analysis
CVE-2025-15066 is a path traversal vulnerability classified under CWE-22 and CWE-862 affecting Innorix WP, a product by Innorix. The vulnerability arises from improper limitation of pathnames to restricted directories, allowing an attacker to traverse directories beyond the intended scope. Specifically, if an 'exam' directory exists under the installation directory (e.g., innorix/exam), the product fails to properly restrict pathname inputs, enabling unauthorized access to files outside the intended directory. The vulnerability does not require authentication or user interaction but does require local access (AV:L), meaning an attacker must have some level of access to the system to exploit it. The CVSS 4.0 base score is 6.9 (medium severity), reflecting a moderate impact primarily on confidentiality due to unauthorized file access. The vulnerability does not affect integrity or availability directly and does not involve network attack vectors. No patches or known exploits are currently available, indicating the need for proactive mitigation. The issue was published on December 29, 2025, and remains a concern for all versions of Innorix WP where the 'exam' directory exists. The vulnerability is significant because it can lead to unauthorized disclosure of sensitive information, potentially exposing confidential data or configuration files critical to system security.
Potential Impact
For European organizations, this vulnerability poses a risk of unauthorized disclosure of sensitive information stored within or accessible via the Innorix WP installation directories. Organizations in sectors such as education, healthcare, or government that may use Innorix WP with the 'exam' directory are particularly vulnerable. The impact is primarily on confidentiality, as attackers can read files outside the intended directory scope. This could lead to exposure of personal data, intellectual property, or system configuration files, potentially facilitating further attacks. Since exploitation requires local access, the threat is higher in environments where multiple users have system access or where attackers can gain initial footholds through other means. The lack of authentication requirement means that once local access is obtained, attackers can exploit the vulnerability without further barriers. The absence of known exploits in the wild reduces immediate risk but does not eliminate the potential for future exploitation. European organizations must consider this vulnerability in their risk assessments, especially those with Innorix WP deployments in critical infrastructure or regulated industries subject to strict data protection regulations like GDPR.
Mitigation Recommendations
1. Immediately verify if the 'exam' directory exists under the Innorix WP installation path; if it is not required, remove or rename it to prevent exploitation. 2. Implement strict input validation and sanitization on all pathname inputs within Innorix WP to ensure traversal sequences (e.g., '../') are blocked or properly handled. 3. Restrict local access to systems running Innorix WP to trusted users only, employing strong access controls and monitoring. 4. Monitor file system access logs for unusual or unauthorized attempts to access directories outside the intended scope, especially targeting the 'exam' directory or parent directories. 5. If possible, isolate Innorix WP installations in segmented network zones to limit lateral movement in case of compromise. 6. Engage with Innorix vendor support to obtain patches or official guidance once available. 7. Conduct regular security audits and penetration testing focusing on path traversal and authorization bypass vulnerabilities. 8. Educate system administrators and users about the risks of local privilege escalation and path traversal attacks to enhance detection and response capabilities.
Affected Countries
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- FSI
- Date Reserved
- 2025-12-24T04:53:21.615Z
- Cvss Version
- 4.0
- State
- PUBLISHED
Threat ID: 695450b5db813ff03e2bf27b
Added to database: 12/30/2025, 10:22:45 PM
Last enriched: 12/30/2025, 11:22:54 PM
Last updated: 2/7/2026, 3:51:54 AM
Views: 28
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Related Threats
CVE-2026-2071: Buffer Overflow in UTT 进取 520W
HighCVE-2026-25762: CWE-400: Uncontrolled Resource Consumption in adonisjs core
HighCVE-2026-25754: CWE-1321: Improperly Controlled Modification of Object Prototype Attributes ('Prototype Pollution') in adonisjs core
HighCVE-2026-25644: CWE-295: Improper Certificate Validation in datahub-project datahub
HighCVE-2026-25804: CWE-287: Improper Authentication in antrea-io antrea
HighActions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
Need more coverage?
Upgrade to Pro Console in Console -> Billing for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.